Kelun-Biotech to Present Study Results at ESMO 2026
Kelun-Biotech says it will present multiple study results at ESMO 2026.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.
News Feed
2 results loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
Merck Showcases First — Time Pivotal Phase 3 Results From Oncology Pipeline and Continued Innovative Potential of Existing Portfolio at ESMO 2026
For best results when printing this announcement, please click on link below: Merck Showcases First-Time Pivotal Phase 3 Results From Oncology Pipeline and Continued Innovative Potential of Existing Portfolio at ESMO 2026 INTerpath-001 data to be presented in Presidential Symposium, featuring the first Phase 3 results